Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 7, 2025

Optical Control of Living Cells Electrical Activity by Conjugated Polymers
10:16

Optical Control of Living Cells Electrical Activity by Conjugated Polymers

Published on: January 28, 2016

7.6K

Recent Advances in Optically Controlled PROTAC.

Muzi Ouyang1,2, Ying Feng1, Hui Chen1,2

  • 1State Key Laboratory of Chemical Oncogenomics, Institute of Biomedical and Health Engineering, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China.

Bioengineering (Basel, Switzerland)
|December 23, 2023
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term sero-epidemiological trends of Nine respiratory pathogens in a predominantly pediatric population in Southwest China: a multicenter retrospective study (2019-2023).

BMC infectious diseases·2026
Same author

Coordination and π-π Stacking-Driven Conjugated Polymer Sensor Array for Polyphenol Fingerprinting and Tea Discrimination.

Analytical chemistry·2026
Same author

Pretargeted PROTAC Strategy Enables Precise Tumor Target Degradation <i>via</i> Self-Assembling Peptides.

ACS applied materials & interfaces·2026
Same author

On Cybervictimization and Cyberbullying Among Chinese Adolescents: The Moderating Role of the Dark Triad Traits and Parental Psychological Control.

Journal of adolescence·2026
Same author

Technological innovations and breakthrough pathways in syphilis diagnosis: addressing global resurgence and the journey toward elimination.

Frontiers in cellular and infection microbiology·2026
Same author

Integrating single-cell and spatial transcriptomics to reveal the spatiotemporal dynamics of retinal cells during ischemia-reperfusion injury progression in rats.

Cell & bioscience·2026
Same journal

Correction: Komatsu et al. Three-Dimensional Visualization and Detection of the Pulmonary Venous-Left Atrium Connection Using Artificial Intelligence in Fetal Cardiac Ultrasound Screening. <i>Bioengineering</i> 2026, <i>13</i>, 100.

Bioengineering (Basel, Switzerland)·2026
Same journal

Comparison of CO<sub>2</sub> Laser and Microdebrider in the Surgical Treatment of Pediatric Recurrent Respiratory Papillomatosis: A Retrospective Analysis.

Bioengineering (Basel, Switzerland)·2026
Same journal

Toward More Translational Tumor Models: Breast dECM-Based 3D Systems Capture Native Microenvironmental Cues.

Bioengineering (Basel, Switzerland)·2026
Same journal

Postural Stability Changes During the 4 Phases of the Half Squat: Kinematics Profile of the Center of Pressure and Center of Mass in High-Performance Weightlifters-A Pilot Study.

Bioengineering (Basel, Switzerland)·2026
Same journal

Definite Implant Position as Novel Readout for Effectiveness of Ridge Preservation Indicates to Beneficial Effect of Combined Treatment with Platelet-Rich Fibrin (PRF) and Xenogenic Biomaterial in Bone Regeneration.

Bioengineering (Basel, Switzerland)·2026
Same journal

Trueness and Precision of Intraoral Scanners for 3D-Printed Orthodontic Models with Attachments: An In Vitro Comparative Study.

Bioengineering (Basel, Switzerland)·2026
See all related articles

Optically controlled proteolysis-targeting chimeras (PROTACs) offer a novel anti-cancer therapy by selectively degrading disease proteins. Enhancing PROTAC specificity improves safety and expands therapeutic applications in drug discovery.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Proteolysis-targeting chimera (PROTAC) technology degrades disease-inducing proteins.
  • Current PROTACs face challenges with target selectivity, leading to potential toxicity in normal cells.
  • Enhancing target specificity is crucial for improving PROTAC safety and efficacy.

Purpose of the Study:

  • To review optically controlled PROTACs as anti-cancer therapies.
  • To explore the clinical applications, efficacy, and safety challenges of these advanced PROTACs.
  • To highlight the potential of optically controlled PROTACs in drug discovery.

Main Methods:

  • Review of current literature on optically controlled PROTACs.
  • Analysis of clinical studies and pre-clinical data on PROTAC efficacy and safety.
Keywords:
NIRPROTACoptogeneticstargeted degradation

More Related Videos

Patterning via Optical Saturable Transitions - Fabrication and Characterization
08:19

Patterning via Optical Saturable Transitions - Fabrication and Characterization

Published on: December 11, 2014

6.9K
A Protocol for Real-time 3D Single Particle Tracking
10:16

A Protocol for Real-time 3D Single Particle Tracking

Published on: January 3, 2018

14.9K

Related Experiment Videos

Last Updated: Jul 7, 2025

Optical Control of Living Cells Electrical Activity by Conjugated Polymers
10:16

Optical Control of Living Cells Electrical Activity by Conjugated Polymers

Published on: January 28, 2016

7.6K
Patterning via Optical Saturable Transitions - Fabrication and Characterization
08:19

Patterning via Optical Saturable Transitions - Fabrication and Characterization

Published on: December 11, 2014

6.9K
A Protocol for Real-time 3D Single Particle Tracking
10:16

A Protocol for Real-time 3D Single Particle Tracking

Published on: January 3, 2018

14.9K
  • Exploration of strategies for enhancing PROTAC target specificity.

    • Main Results:

    • Optically controlled PROTACs demonstrate promise as targeted anti-cancer agents.
    • Modifications to PROTACs are being explored to improve selectivity and reduce off-target effects.
    • Clinical application of optically controlled PROTACs is an active area of research.

    Conclusions:

    • Optically controlled PROTACs represent an innovative therapeutic strategy for cancer treatment.
    • Further research is needed to overcome challenges in efficacy and safety for broader clinical use.
    • This technology has the potential to significantly advance drug discovery and personalized medicine.